A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Lensar, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 210,552 shares of LNSR stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
210,552
Previous 236,710 11.05%
Holding current value
$2.15 Million
Previous $3.12 Million 18.16%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$12.04 - $13.32 $314,942 - $348,424
-26,158 Reduced 11.05%
210,552 $2.55 Million
Q2 2025

Aug 14, 2025

SELL
$12.22 - $14.18 $492,368 - $571,340
-40,292 Reduced 14.55%
236,710 $3.12 Million
Q1 2025

May 15, 2025

BUY
$7.66 - $16.87 $2.12 Million - $4.67 Million
277,002 New
277,002 $3.91 Million

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $112M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.